Sort
50,496 grants matching “lung cancer”
The ALK receptor tyrosine kinase as a therapeutic target in neuroblastoma
$413,844Rani E George · Dana-Farber Cancer Inst · R01 · FY2018 · CA
Health, Aging and Body Composition Study
$413,748Tamara Harris · Aging · Z01 · FY2007 · AG
Regulation of and Target Recognition by Protein Arginine Methyltransferase 1 (PRMT1)
$413,745Joan M Hevel · Utah State University · R15 · FY2023 · GM
Role of Osterix+ Osteolineage Cells in Primary and Metastatic Breast Cancer
$413,711Roberta Faccio · Washington University · R01 · FY2025 · CA
Arsenic Exposure and Birth Outcomes in Bangladesh
$413,697David C Christiani · Harvard School Of Public Health · R01 · FY2011 · ES
The Development of First-in-Class Inhibitors of Oncogenic CHD1L for the Treatment of Colorectal Cancer.
$413,649Daniel V. Labarbera · University Of Colorado Denver · R01 · FY2022 · CA
SESN2 and therapeutic effect of Isohapontigenin (ISO)
$413,616Max Costa · New York University School Of Medicine · R01 · FY2022 · CA
Establishing MAGE-A4/RAD18 as a novel cancer-specific chemotherapeutic target
$413,559Cyrus Vaziri · Univ Of North Carolina Chapel Hill · R01 · FY2019 · CA
COBRE: NDS U: SYNTHESIS: BONE, LUNG, EMPHYSEMA, ALZHEIMER, CANCER, DRUG DVMT
$413,518North Dakota State University · P20 · FY2005 · RR
ETHANOL MEDIATED CILIA MOTILITY DYSFUNCTION
$413,497University Of Nebraska Medical Center · R01 · FY2003 · AA
Reversing epithelial-mesenchymal transition in metastatic cancer cells using engineered nanomaterials and a mild photothermal effect
$413,479Congzhou Wang · South Dakota School Of Mines And Techn'Y · R15 · FY2022 · CA
A low-cost, multiplexed digital high resolution melt platform for DNA methylation-based detection and identification of cancers in liquid biopsies
$413,468Tza-Huei Jeff Wang · Johns Hopkins University · R33 · FY2023 · CA
Biomechanical Regulation of Organ Growth
$413,466Kenneth D Irvine · Rutgers, The State Univ Of N.J. · R01 · FY2017 · GM
Biomechanical Regulation of Organ Growth
$413,466Kenneth D Irvine · Rutgers, The State Univ Of N.J. · R01 · FY2018 · GM
Targeting PKR-Bcl2 Signaling to Overcome Paclitaxel Resistance in Ovarian Cancer
$413,431Jixin Dong · University Of Nebraska Medical Center · R01 · FY2022 · CA
Training Program in Cancer Biology
$413,418Massachusetts General Hospital · T32 · FY2002 · CA
Accelerating biomarker development through novel statistical methods for analyzing phase III/IV studies
$413,415Ying Huang · Fred Hutchinson Cancer Center · R01 · FY2023 · CA
Project 3: MANCR Mediates Epigenetic Mechanisms for Survival of Advanced Breast Cancer
$413,407Janet L Stein · University Of Vermont & St Agric College · P01 · FY2025 · CA
Development of statistical genetics methodology
$413,395Joan E. Bailey-Wilson · Human Genome Research · Z01 · FY2007 · HG
Multidisciplinary research training in pulmonary diseases
$413,326Claire M Doerschuk · Univ Of North Carolina Chapel Hill · T32 · FY2013 · HL
Therapeutic Targeting of Breast Cancer Tumor Initiating Cells
$413,297Charles M Perou · Univ Of North Carolina Chapel Hill · R01 · FY2021 · CA
Therapeutic Targeting of Breast Cancer Tumor Initiating Cells
$413,297Charles M Perou · Univ Of North Carolina Chapel Hill · R01 · FY2025 · CA
Therapeutic Targeting of Breast Cancer Tumor Initiating Cells
$413,297Charles M Perou · Univ Of North Carolina Chapel Hill · R01 · FY2023 · CA
Alaska Native Tumor Registry as SEER Registry
$413,281National Cancer Institute · Y01 · FY2009 · CA
Neu5Gc and anti-Neu5Gc antibodies for detection of cancer and cancer risk
$413,250Ajit P Varki · University Of California, San Diego · U01 · FY2009 · CA